Engineered Bacteria Fight Pancreatic Cancer | Science News

Science News Today | 2 Min News | The Daily News Now! · Aug 19, 2026 · 2m

Scientists have engineered gut-friendly bacteria to become microscopic drug factories that target pancreatic tumors, showing promising results in animal studies. By modifying Bifidobacterium longum to deliver a potent immune-boosting molecule directly into tumors, the therapy activates cancer-fighting T cells while avoiding systemic side effects. These bacteria naturally seek out the oxygen-poor tumor environment, making them ideal delivery vehicles. When combined with chemotherapy, radiation, or immunotherapy, the treatment significantly improved tumor control and survival rates. Though…